Roberts, R L
Wallace, M C
Phipps-Green, A J
Topless, R
Drake, J M
Tan, P
Dalbeth, N
Merriman, T R
Stamp, L K
Article History
Received: 12 August 2015
Revised: 19 October 2015
Accepted: 16 November 2015
First Online: 26 January 2016
Competing interests
: Dalbeth, Stamp, Merriman and Roberts report grants from the Health Research Council of New Zealand, during the conduct of the study and from Ardea Biosciences for related work that is not part of this manuscript. Dalbeth reports personal fees from Takeda, Teijin, Menarini, Pfizer and Cymabay, grants and personal fees from AstraZeneca, Ardea Biosciences and Fonterra, outside the submitted work. In addition, Dalbeth has a patent Milk Products for Gout pending. Stamp reports consulting fees from Astra Zeneca unrelated to the submitted work.